Galecto Inc is a biotechnology business based in the US. Galecto shares (GLTO) are listed on the NASDAQ and all prices are listed in US Dollars. Galecto employs 28 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in Galecto
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – GLTO – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Galecto stock price (NASDAQ: GLTO)Use our graph to track the performance of GLTO stocks over time.
Galecto shares at a glance
|Latest market close||$3.40|
|52-week range||$3.34 - $17.99|
|50-day moving average||$3.90|
|200-day moving average||$4.75|
|Wall St. target price||$13.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-2.86|
Buy Galecto shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Galecto stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Galecto price performance over time
|1 week (2021-10-15)||-0.58%|
|1 month (2021-09-24)||-11.69%|
|3 months (2021-07-23)||-22.73%|
|6 months (2021-04-23)||-43.33%|
|1 year (2020-10-21)||N/A|
|2 years (2019-10-21)||N/A|
|3 years (2018-10-21)||N/A|
|5 years (2016-10-21)||N/A|
|Gross profit TTM||$0|
|Return on assets TTM||-31.48%|
|Return on equity TTM||-54.76%|
|Market capitalisation||$86.4 million|
TTM: trailing 12 months
Shorting Galecto shares
There are currently 48,291 Galecto shares held short by investors – that's known as Galecto's "short interest". This figure is 41.9% down from 83,176 last month.
There are a few different ways that this level of interest in shorting Galecto shares can be evaluated.
Galecto's "short interest ratio" (SIR)
Galecto's "short interest ratio" (SIR) is the quantity of Galecto shares currently shorted divided by the average quantity of Galecto shares traded daily (recently around 86233.928571429). Galecto's SIR currently stands at 0.56. In other words for every 100,000 Galecto shares traded daily on the market, roughly 560 shares are currently held short.
To gain some more context, you can compare Galecto's short interest ratio against those of similar companies.
However Galecto's short interest can also be evaluated against the total number of Galecto shares, or, against the total number of tradable Galecto shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Galecto's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Galecto shares in existence, roughly 0 shares are currently held short) or 0.0039% of the tradable shares (for every 100,000 tradable Galecto shares, roughly 4 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Galecto.
Find out more about how you can short Galecto stock.
Galecto share dividends
We're not expecting Galecto to pay a dividend over the next 12 months.
You may also wish to consider:
- Gilead Sciences (GILD.US) (4.15% forward annual dividend yield)
Galecto, Inc. , a clinical-stage biotechnology company, develops molecules for the treatment of fibrosis, cancer, inflammation, and other related diseases. The company's lead product candidate is GB0139, an inhaled inhibitor of galectin-3 that is in Phase IIb clinical trial for the treatment of severe fibrotic lung diseases, such as idiopathic pulmonary fibrosis, a life-threatening progressive fibrotic disease of the lung. Its products also comprise GB2064, which is in Phase I/IIa for the treatment of myelofibrosis; and GB1211, a selective oral galectin-3 inhibitor that is in Phase I/IIa for the treatment of cancer and fibrosis. Galecto, Inc. was founded in 2011 and is based in Boston, Massachusetts. .
Galecto in the news
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results
The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
Frequently asked questionsWhat percentage of Galecto is owned by insiders or institutions?
Currently 11.418% of Galecto shares are held by insiders and 51.422% by institutions. How many people work for Galecto?
Latest data suggests 28 work at Galecto. When does the fiscal year end for Galecto?
Galecto's fiscal year ends in December. Where is Galecto based?
Galecto's address is: 75 State Street, Boston, MA, United States, 02109 What is Galecto's ISIN number?
Galecto's international securities identification number is: US36322Q1076
More guides on Finder
How to buy ProShares Bitcoin Strategy ETF (BITO)
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
How to buy The Real Good Food Company (RGF) stock when it goes public
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
How to buy Lulu’s Fashion Lounge Holdings (LVLU) stock when it goes public
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
How to buy Allarity Therapeutics (ALLR) stock when it goes public
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
How to buy Jupiter Neurosciences (JUNS) stock when it goes public
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
How to buy Mainz Biomed (MYNZ) stock when it goes public
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
How to buy Progressive Care stock when it goes public
Everything we know about the Progressive Care IPO, plus information on how to buy in.
How to buy Desert Peak Minerals (DPM) stock when it goes public
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
How to buy Vaxxinity (VAXX) stock when it goes public
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
How to buy Entrada Therapeutics (TRDA) stock when it goes public
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
Ask an Expert